BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 29494220)

  • 1. Cytology Smears in the Era of Molecular Biomarkers in Non-Small Cell Lung Cancer: Doing More With Less.
    Lozano MD; Echeveste JI; Abengozar M; Mejías LD; Idoate MA; Calvo A; de Andrea CE
    Arch Pathol Lab Med; 2018 Mar; 142(3):291-298. PubMed ID: 29494220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK and ROS1 rearrangement tested by ARMS-PCR in non-small-cell lung cancer patients via cytology specimens: The experience of Shanghai Pulmonary Hospital.
    Cao Z; Wu W; Zhang W; Li Z; Gao C; Huang Y; Zhang L
    Diagn Cytopathol; 2020 Jun; 48(6):524-530. PubMed ID: 32150350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytology samples and molecular biomarker testing in lung cancer-advantages and challenges.
    Canberk S; Engels M
    Virchows Arch; 2021 Jan; 478(1):45-57. PubMed ID: 33389149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment.
    Proietti A; Alì G; Pelliccioni S; Lupi C; Sensi E; Boldrini L; Servadio A; Chella A; Ribechini A; Cappuzzo F; Miccoli M; Fontanini G
    Cancer Cytopathol; 2014 Jun; 122(6):445-53. PubMed ID: 24648382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Pathology of Lung Cancer Cytology Specimens: A Concise Review.
    Jain D; Roy-Chowdhuri S
    Arch Pathol Lab Med; 2018 Sep; 142(9):1127-1133. PubMed ID: 29547001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALK status testing in non-small-cell lung carcinoma by FISH on ThinPrep slides with cytology material.
    Minca EC; Lanigan CP; Reynolds JP; Wang Z; Ma PC; Cicenia J; Almeida FA; Pennell NA; Tubbs RR
    J Thorac Oncol; 2014 Apr; 9(4):464-8. PubMed ID: 24736067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemistry for predictive biomarker testing in lung cancer cytology.
    Jain D; Nambirajan A; Borczuk A; Chen G; Minami Y; Moreira AL; Motoi N; Papotti M; Rekhtman N; Russell PA; Savic Prince S; Yatabe Y; Bubendorf L;
    Cancer Cytopathol; 2019 May; 127(5):325-339. PubMed ID: 31050216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor cell block adequacy rate for molecular testing improved with the addition of Diff-Quik-stained smears: Need for better cell block processing.
    Harada S; Agosto-Arroyo E; Levesque JA; Alston E; Janowski KM; Coshatt GM; Eltoum IA
    Cancer Cytopathol; 2015 Aug; 123(8):480-7. PubMed ID: 25955105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
    Kanaji N; Bandoh S; Ishii T; Tadokoro A; Watanabe N; Takahama T; Haba R; Imataki O; Dobashi H; Matsunaga T
    Lung Cancer; 2012 Aug; 77(2):293-8. PubMed ID: 22494566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung Carcinoma Predictive Biomarker Testing by Immunoperoxidase Stains in Cytology and Small Biopsy Specimens: Advantages and Limitations.
    Zhou F; Moreira AL
    Arch Pathol Lab Med; 2016 Dec; 140(12):1331-1337. PubMed ID: 27588333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
    Li W; Zhang Z; Guo L; Qiu T; Ling Y; Cao J; Guo H; Zhao H; Li L; Ying J
    Oncotarget; 2016 Feb; 7(7):8332-40. PubMed ID: 26789109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1 expression in non-small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens.
    Heymann JJ; Bulman WA; Swinarski D; Pagan CA; Crapanzano JP; Haghighi M; Fazlollahi L; Stoopler MB; Sonett JR; Sacher AG; Shu CA; Rizvi NA; Saqi A
    Cancer Cytopathol; 2017 Dec; 125(12):896-907. PubMed ID: 29024471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry.
    Bonaparte E; Pesenti C; Fontana L; Falcone R; Paganini L; Marzorati A; Ferrero S; Nosotti M; Mendogni P; Bareggi C; Sirchia SM; Tabano S; Bosari S; Miozzo M
    Diagn Pathol; 2018 Jan; 13(1):4. PubMed ID: 29368620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.
    Betz BL; Dixon CA; Weigelin HC; Knoepp SM; Roh MH
    Cancer Cytopathol; 2013 Sep; 121(9):489-99. PubMed ID: 23536384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical performance of endobronchial ultrasound-guided transbronchial needle aspiration for assessing programmed death ligand-1 expression in nonsmall cell lung cancer.
    Biswas A; Leon ME; Drew P; Fernandez-Bussy S; Furtado LV; Jantz MA; Mehta HJ
    Diagn Cytopathol; 2018 May; 46(5):378-383. PubMed ID: 29476608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of epidermal growth factor receptor mutation analysis on cytology smears and surgical pathology specimens from primary and metastatic lung carcinomas.
    Khode R; Larsen DA; Culbreath BC; Parrish S; Walker KL; Sayage-Rabie L; Beissner RS; Rao A
    Cancer Cytopathol; 2013 Jul; 121(7):361-9. PubMed ID: 23364874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Cost Implications of Universal Versus Locally Advanced-Stage and Advanced-Stage-Only Molecular Testing for Epidermal Growth Factor Receptor Mutations and Anaplastic Lymphoma Kinase Rearrangements in Non-Small Cell Lung Carcinoma: A Tertiary Academic Institution Experience.
    Sauter JL; Butnor KJ
    Arch Pathol Lab Med; 2016 Apr; 140(4):358-61. PubMed ID: 27028394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Adequacy of Small Biopsy and Fine-Needle Aspiration Specimens for Molecular Testing by Next-Generation Sequencing in Patients With Lung Cancer: A Quality Improvement Study at Dartmouth-Hitchcock Medical Center.
    Padmanabhan V; Steinmetz HB; Rizzo EJ; Erskine AJ; Fairbank TL; de Abreu FB; Tsongalis GJ; Tafe LJ
    Arch Pathol Lab Med; 2017 Mar; 141(3):402-409. PubMed ID: 27763790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of EGFR and KRAS mutation analysis on fine-needle aspiration washing in non-small cell lung cancer.
    Bozzetti C; Naldi N; Nizzoli R; Azzoni C; Bortesi B; Zobbi V; Bottarelli L; Tiseo M; Gasparro D; Majori M; De Filippo M; Ardizzoni A
    Lung Cancer; 2013 Apr; 80(1):35-8. PubMed ID: 23352033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor biomarker testing in non-small-cell lung cancer: A decade of change.
    VanderLaan PA; Rangachari D; Majid A; Parikh MS; Gangadharan SP; Kent MS; McDonald DC; Huberman MS; Kobayashi SS; Costa DB
    Lung Cancer; 2018 Feb; 116():90-95. PubMed ID: 29413057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.